- Report
- October 2025
- 82 Pages
Saudi Arabia
From €4281EUR$4,850USD£3,690GBP
- Report
- March 2025
- 197 Pages
Global
From €4369EUR$4,950USD£3,766GBP
- Report
- March 2025
- 110 Pages
Global
From €2604EUR$2,950USD£2,245GBP
- Report
- March 2025
- 82 Pages
Middle East, Africa
From €2604EUR$2,950USD£2,245GBP
- Report
- March 2025
- 82 Pages
From €2604EUR$2,950USD£2,245GBP
- Report
- March 2025
- 96 Pages
Asia Pacific
From €3045EUR$3,450USD£2,625GBP
- Report
- March 2025
- 99 Pages
Europe
From €3045EUR$3,450USD£2,625GBP
- Report
- March 2025
- 88 Pages
North America
From €2604EUR$2,950USD£2,245GBP
- Report
- August 2024
- 298 Pages
China
From €3531EUR$4,000USD£3,044GBP
- Report
- January 2024
- 211 Pages
Global
From €4899EUR$5,550USD£4,223GBP
- Report
- October 2023
- 689 Pages
Global
From €8823EUR$9,995USD£7,605GBP
- Report
- August 2023
- 85 Pages
United States
From €4281EUR$4,850USD£3,690GBP
- Report
- June 2021
- 40 Pages
Global
€1163EUR$1,318USD£1,003GBP
- Report
- October 2024
- 91 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- April 2022
- 91 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- July 2024
- 153 Pages
Global
From €3189EUR$3,613USD£2,749GBP
€3751EUR$4,250USD£3,234GBP
- Report
- November 2025
- 89 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- August 2023
- 116 Pages
Global
From €3500EUR$4,248USD£3,123GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more